KPIs & Operating Metrics(New)
Aesthetics Revenue By CategoryAesthetics Revenue By Category AnnualAesthetics Revenue By GeographyAesthetics Revenue By Geography AnnualBreakdown Of AssetsEmployee StatisticsEye Care Revenue By CategoryEye Care Revenue By Category AnnualEye Care Revenue By GeographyEye Care Revenue By Geography AnnualGross MarginGross Margin %Gross Margin AnnualGross Margin Annual %Hematology Oncology Revenue By CategoryHematology Oncology Revenue By Category AnnualHematology Oncology Revenue By GeographyHematology Oncology Revenue By Geography AnnualImmunology Revenue By CategoryImmunology Revenue By Category AnnualImmunology Revenue By GeographyImmunology Revenue By Geography AnnualIncome Before Income Taxes By RegionLong Lived Assets By RegionNeuroscience Revenue By CategoryNeuroscience Revenue By Category AnnualNeuroscience Revenue By GeographyNeuroscience Revenue By Geography AnnualNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of RevenueOPEX SegregationOther Key Products Revenue By CategoryOther Key Products Revenue By Category AnnualOther Key Products Revenue By GeographyOther Key Products Revenue By Geography AnnualProperty & Equipment BreakdownRevenueRevenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Revenue By Ship To LocationRevenue By Ship To Location %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Gross Margin (2016 - 2025)

Historic Gross Margin for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to 66.38%.

  • AbbVie's Gross Margin fell 44900.0% to 66.38% in Q3 2025 from the same period last year, while for Sep 2025 it was 69.74%, marking a year-over-year increase of 25400.0%. This contributed to the annual value of 69.99% for FY2024, which is 75800.0% up from last year.
  • Per AbbVie's latest filing, its Gross Margin stood at 66.38% for Q3 2025, which was down 44900.0% from 71.82% recorded in Q2 2025.
  • In the past 5 years, AbbVie's Gross Margin ranged from a high of 72.42% in Q4 2022 and a low of 53.44% during Q3 2023
  • Over the past 5 years, AbbVie's median Gross Margin value was 69.42% (recorded in 2023), while the average stood at 68.08%.
  • Its Gross Margin has fluctuated over the past 5 years, first tumbled by -126600bps in 2023, then skyrocketed by 174400bps in 2024.
  • Over the past 5 years, AbbVie's Gross Margin (Quarter) stood at 70.98% in 2021, then rose by 2bps to 72.42% in 2022, then dropped by -17bps to 60.11% in 2023, then grew by 18bps to 70.89% in 2024, then decreased by -6bps to 66.38% in 2025.
  • Its last three reported values are 66.38% in Q3 2025, 71.82% for Q2 2025, and 70.01% during Q1 2025.